Oramed Pharmaceuticals Inc. — Director's Dealing 2023

Mar 15, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAMED PHARMACEUTICALS INC. (ORMP)
CIK: 0001176309
Period of Report: 2023-03-14

Reporting Person: KIDRON NADAV (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-14	Common Stock	P	100000	$2.01	Acquired	100000	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1053098	Direct